International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: 10.5281/zenodo.13704886
Original Research Article
Histopathological Spectrum of Vesiculobullous Lesions of the Skin at Tertiary Care Centre
Published
Sept. 6, 2024
Abstract

Background: Vesiculobullous lesions present with fluid filled cavity within or beneath the epidermis or mucous membrane or both. Various type of pathologic process includes inflammatory, autoimmune, infective, drug induced or genetic causes can lead to development of vesiculobullous eruption. Methods: In this study 65 clinically diagnosed cases of vesiculobullous lesions were included from January -2019 to December -2022. Clinical data like age, sex, duration & site of lesion, history of any disease or drug, any significant family or personal history noted. Punch biopsy has been taken and after processing and staining with haematoxylin-eosin it was examined under the microscope. Results:Vesiculobullous lesions were seen among 5 years to 92 years of age. Out of 65 cases 35 were male and 30 females. In present study Pemphigus Vulgaris was most common -16 cases (24.6%) followed by Bullous Pemphigoid -13 cases (20%). 10 cases of Pemphigus Foliaceus, 8 cases of Steven Johnson Syndrome & 4 cases each of Hailey Hailey disease & Linear IgA dermatosis were reported. 3 cases each of Dermatitis herpetiform&Darier’s disease were also reported – less common lesion include Sub corneal pustulardermatosis, Bullous fixed drug reaction (1 case each). In 2 cases of vesiculobullous lesions further Direct Immunofluorescence technique (DIF) required to confirm accurate diagnosis.Conclusion: Histopathological examination along with clinical correlation is required to confirm the diagnosis of vesiculobullous lesions and in some cases, direct immunofluorescence is required for final diagnosis.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
1425 Views
323 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved